TERT and adrenal cortex carcinoma: A prior study of pediatric adrenocortical carcinomas had documented a high incidence of TERT amplifications in a relatively small cohort of patients (13 of 19, 68.4%) without evaluating for “hotspot” promoter mutation status [26].